+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compound heterozygous mutations affect protein folding and function in patients with congenital sucrase-isomaltase deficiency

Compound heterozygous mutations affect protein folding and function in patients with congenital sucrase-isomaltase deficiency

Gastroenterology 136(3): 883-892

Congenital sucrase-isomaltase (SI) deficiency is an autosomal-recessive intestinal disorder characterized by a drastic reduction or absence of sucrase and isomaltase activities. Previous studies have indicated that single mutations underlie individual phenotypes of the disease. We investigated whether compound heterozygous mutations, observed in some patients, have a role in disease pathogenesis. We introduced mutations into the SI complementary DNA that resulted in the amino acid substitutions V577G and G1073D (heterozygous mutations found in one group of patients) or C1229Y and F1745C (heterozygous mutations found in another group). The mutant genes were expressed transiently, alone or in combination, in COS cells and the effects were assessed at the protein, structural, and subcellular levels. The mutants SI-V577G, SI-G1073D, and SI-F1745C were misfolded and could not exit the endoplasmic reticulum, whereas SI-C1229Y was transported only to the Golgi apparatus. Co-expression of mutants found on each SI allele in patients did not alter the protein's biosynthetic features or improve its enzymatic activity. Importantly, the mutations C1229Y and F1745C, which lie in the sucrase domains of SI, prevented its targeting to the cell's apical membrane but did not affect protein folding or isomaltase activity. Compound heterozygosity is a novel pathogenic mechanism of congenital SI deficiency. The effects of mutations in the sucrase domain of SIC1229Y and SIF1745C indicate the importance of a direct interaction between isomaltase and sucrose and the role of sucrose as an intermolecular chaperone in the intracellular transport of SI.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 052269133

Download citation: RISBibTeXText

PMID: 19121318

DOI: 10.1053/j.gastro.2008.11.038

Related references

Congenital Sucrase-isomaltase Deficiency: A Novel Compound Heterozygous Mutation Causing Aberrant Protein Localization. Journal of Pediatric Gastroenterology and Nutrition 64(5): 770-776, 2017

Molecular pathogenicity of novel sucrase-isomaltase mutations found in congenital sucrase-isomaltase deficiency patients. Biochimica et Biophysica Acta. Molecular Basis of Disease 1863(3): 817-826, 2017

Congenital sucrase isomaltase deficiency csid in man evidence for different mutations of interfering with the intracellular transport of sucrase isomaltase. Experientia 44(ABSTR): A64, 1988

Intracellular transport of sucrase isomaltase in patients with a congenital sucrase isomaltase deficiency. Ultramicroscopy 27(2): 204, 1989

Transport to cell surface of intestinal sucrase-isomaltase is blocked in the Golgi apparatus in a patient with congenital sucrase-isomaltase deficiency. Proceedings of the National Academy of Sciences of the United States of America 82(13): 4423-4427, 1985

Congenital sucrase-isomaltase deficiency. Identification of a glutamine to proline substitution that leads to a transport block of sucrase-isomaltase in a pre-Golgi compartment. Journal of Clinical Investigation 97(3): 633-641, 1996

Liquid yeast derived sucrase ys to treat patients with congenital sucrase isomaltase deficiency sid. Gastroenterology 102(4 Part 2): A248, 1992

Altered folding, turnover, and polarized sorting act in concert to define a novel pathomechanism of congenital sucrase-isomaltase deficiency. Journal of Biological Chemistry 281(20): 14393-9, 2006

In vitro investigation of yeast derived sucrase ys used to treat congenital sucrase isomaltase deficiency sid. Gastroenterology 102(4 Part 2): A196, 1992

Starch digestion and patients with congenital sucrase-isomaltase deficiency. Journal of Pediatric Gastroenterology and Nutrition 55(Suppl. 2): S24-S28, 2012

Biosynthesis of sucrase-isomaltase. Purification and NH2-terminal amino acid sequence of the rat sucrase-isomaltase precursor (pro-sucrase-isomaltase) from fetal intestinal transplants. Journal of Biological Chemistry 257(8): 4522-4528, 1982

Phenotype II congenital sucrase-isomaltase deficiency is caused by a mutation in a highly conserved region of the sucrase subunit. European Journal of Cell Biology 63(Suppl. 40): 10, 1994

Sucrase isomaltase deficiency in man different mutations disrupt intracellular transport and function of an intestinal microvillar hydrolase. Journal of Cell Biology 105(4 Part 2): 59A, 1987

Congenital sucrase-isomaltase deficiency: heterogeneity of inheritance, trafficking, and function of an intestinal enzyme complex. Journal of Pediatric Gastroenterology and Nutrition 55(Suppl. 2): S13-S20, 2012

N-Terminal sequences of pig intestinal sucrase-isomaltase and pro-sucrase--isomaltase. Implications for the biosynthesis and membrane insertion of pro-sucrase--isomaltase. Febs Letters 148(2): 321-325, 1982